Lee Sang-Ah, Kim Jae Weon, Roh Ju Won, Choi Ji Yeob, Lee Kyoung-Mu, Yoo Keun-Young, Song Yong Sang, Kang Daehee
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Gynecol Oncol. 2004 Apr;93(1):14-8. doi: 10.1016/j.ygyno.2003.11.045.
The aim of this study was to determine whether GSTM1 or GSTT1 might be associated with risk of cervical cancer development in Korean women. The multiplicative interaction of GSTM1 and GSTT1 genotype with p21, p53 polymorphism, and HPV genotype was also investigated.
From 1997 to 1999, uterine cervical carcinoma was diagnosed in 215 Korean women at the Department of Obstetrics and Gynecology of Seoul National University Hospital. None of the women in the control groups (n = 98) had any evidence of cervical lesions, which were confirmed by Pap smear. Finally, 81 cases and 86 controls were genotyped for p21, p53, and GSTM1 and T1 and HPV infection. A multiplex PCR method was used for the genotyping of GSTM1 and GSTT1; direct sequencing for p53 codon 72, high-risk HPV, and PCR-RFLP (BsmAI) for p21 codon. The unconditional logistic regression analysis was used to calculate ORs and 95% CI.
Although the GSTM1 and GSTT1 genotype was not significantly associated with cervical cancer development for all women, the GSTM1 null genotype was significantly associated with an increased risk of cervical cancer development in women with high-risk HPV infection (OR = 2.9, 95% CI: 1.0-8.2). Although the frequency of overall GSTT1 null genotype was significantly lower in cervical carcinoma patients with high-risk HPV infection (OR = 0.3, 95% CI: 0.1-1.0), almost 2-fold increased risk was observed among women with GSTT1 null and Arg/Arg genotype (OR = 1.9, 95% CI: 0.7-5.4). Although the cervical cancer risk was 3.3-fold increased in women with null and Arg/Arg genotype compared to women with GSTM1 present and p21 Ser-containing genotype, there was no significant multiplicative interaction between GSTM1 and p21 (P for interaction = 0.785) or p53 (P for interaction = 0.815).
These findings suggest that the risk of cervical cancer may be related to GSTM1 genotype in women with high-risk HPV infection and that there is a possible gene-gene interaction in the incidence of cervical cancer.
本研究旨在确定谷胱甘肽S -转移酶M1(GSTM1)或谷胱甘肽S -转移酶T1(GSTT1)是否可能与韩国女性宫颈癌发生风险相关。同时还研究了GSTM1和GSTT1基因型与p21、p53多态性以及人乳头瘤病毒(HPV)基因型的相乘交互作用。
1997年至1999年期间,首尔国立大学医院妇产科诊断出215例韩国女性患有子宫颈癌。对照组(n = 98)中的女性均无宫颈病变迹象,宫颈病变经巴氏涂片检查确认。最后,对81例病例和86例对照进行了p21、p53、GSTM1和T1基因分型以及HPV感染检测。采用多重聚合酶链反应(PCR)方法对GSTM1和GSTT1进行基因分型;对p53密码子72进行直接测序,对高危型HPV进行检测,对p21密码子采用聚合酶链反应 - 限制性片段长度多态性分析(PCR - RFLP,BsmAI酶切)。采用非条件逻辑回归分析计算比值比(OR)和95%可信区间(CI)。
尽管GSTM1和GSTT1基因型与所有女性的宫颈癌发生无显著相关性,但GSTM1缺失基因型与高危型HPV感染女性宫颈癌发生风险增加显著相关(OR = 2.9,95% CI:1.0 - 8.2)。尽管高危型HPV感染的宫颈癌患者中总体GSTT1缺失基因型频率显著较低(OR = 0.3,95% CI:0.1 - 1.0),但GSTT1缺失和精氨酸/精氨酸(Arg/Arg)基因型的女性中观察到风险几乎增加了2倍(OR = 1.9,95% CI:0.7 - 5.4)。尽管与存在GSTM1且含p21丝氨酸(Ser)基因型的女性相比,缺失和Arg/Arg基因型的女性患宫颈癌风险增加了3.3倍,但GSTM1与p21(交互作用P值 = 0.785)或p53(交互作用P值 = 0.815)之间无显著的相乘交互作用。
这些发现表明,高危型HPV感染女性的宫颈癌风险可能与GSTM1基因型有关,并且在宫颈癌发病中可能存在基因 - 基因交互作用。